← Back to all trials
Active Not Recruiting
NCT05674773
Treatment Outcomes of Advanced Neoplasia in IBD
Conditions: Inflammatory Bowel Diseases
Sex: All
Ages: 18 Years – N/A
Enrollment: 189
Sponsor: Radboud University Medical Center
Location: Netherlands
Summary
In this study, we aimed to (1) compare cumulative incidences of synchronous and metachronous colorectal neoplasia as well as mortality following AN in CD and UC patients who underwent proctocolectomy, (sub)total colectomy, partial colectomy or endoscopic resection, and (2) to determine factors associated with AN treatment choice.
Eligibility Criteria
Inclusion Criteria:IBD (ulcerative colitis (UC), CD or IBD-unclassified (IBD-U))Histological diagnosis of colorectal ANAvailable treatment dataExclusion Criteria:Familial CRC syndromeAN prior to IBD diagnosis
Source: ClinicalTrials.gov (NCT05674773). StuddyBuddy aggregates publicly available trial information.
